Sun Pharma may rally to Rs 695- 697, says Jai Bala

Bala told CNBC-TV18, “Most of the pharmaceutical space, front line stocks are actually showing considerable amount of strength. You have a low-risk trading opportunity here. You can even go long in Sun Pharma with a stop loss of Rs 610-605 and expect the stock to scale closer to Rs 695-697.”

He further added, “There is greater potential but you can be conservative at this point in time. You don’t know how long this outperformance will last. So you can set your objectives slightly lower.”

The company's trailing 12-month (TTM) EPS was at Rs 13.36 per share. (Mar, 2012). The stock's price-to-earnings (P/E) ratio was 48.36. The latest book value of the company is Rs 83.13 per share. At current value, the price-to-book value of the company was 7.77. The dividend yield of the company was 0.54%.